Fibroma other imaging findings: Difference between revisions
Line 11: | Line 11: | ||
They are metabolically active on F18-FDG-PET images.That activity, probably is independent of lesion size, varies among patients and over time, as indicated by their F18-FDG uptake on PET. <ref name="pmid27307893">{{cite journal |vauthors=Pagano M, Berta M, Postini AM, Bianchi M, Del Prever AB, Defilippi C, Ficola U, Cistaro A |title=Nonossifying fibroma: A possible pitfall in F18-FD-PET/CT imaging of Hodgkin's disease |journal=Radiol Case Rep |volume=6 |issue=2 |pages=271 |date=2011 |pmid=27307893 |pmc=4901151 |doi=10.2484/rcr.v6i2.271 |url=}}</ref><ref name="pmid15089082">{{cite journal |vauthors=Betsy M, Kupersmith LM, Springfield DS |title=Metaphyseal fibrous defects |journal=J Am Acad Orthop Surg |volume=12 |issue=2 |pages=89–95 |date=2004 |pmid=15089082 |doi= |url=}}</ref><ref name="pmid16985165">{{cite journal |vauthors=Goodin GS, Shulkin BL, Kaufman RA, McCarville MB |title=PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease |journal=AJR Am J Roentgenol |volume=187 |issue=4 |pages=1124–8 |date=October 2006 |pmid=16985165 |doi=10.2214/AJR.06.0171 |url=}}</ref> | They are metabolically active on F18-FDG-PET images.That activity, probably is independent of lesion size, varies among patients and over time, as indicated by their F18-FDG uptake on PET. <ref name="pmid27307893">{{cite journal |vauthors=Pagano M, Berta M, Postini AM, Bianchi M, Del Prever AB, Defilippi C, Ficola U, Cistaro A |title=Nonossifying fibroma: A possible pitfall in F18-FD-PET/CT imaging of Hodgkin's disease |journal=Radiol Case Rep |volume=6 |issue=2 |pages=271 |date=2011 |pmid=27307893 |pmc=4901151 |doi=10.2484/rcr.v6i2.271 |url=}}</ref><ref name="pmid15089082">{{cite journal |vauthors=Betsy M, Kupersmith LM, Springfield DS |title=Metaphyseal fibrous defects |journal=J Am Acad Orthop Surg |volume=12 |issue=2 |pages=89–95 |date=2004 |pmid=15089082 |doi= |url=}}</ref><ref name="pmid16985165">{{cite journal |vauthors=Goodin GS, Shulkin BL, Kaufman RA, McCarville MB |title=PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease |journal=AJR Am J Roentgenol |volume=187 |issue=4 |pages=1124–8 |date=October 2006 |pmid=16985165 |doi=10.2214/AJR.06.0171 |url=}}</ref> | ||
===Chondromyxoid Fibroma=== | ===Chondromyxoid Fibroma=== | ||
On bone scans, the scintigraphic "doughnut sign" has been described in [[chondromyxoid fibroma]]. However, this is very nonspecific and can be seen in many other bone lesions.<ref name="HamadaTomita2009">{{cite journal|last1=Hamada|first1=Kenichiro|last2=Tomita|first2=Yasuhiko|last3=Konishi|first3=Eiichi|last4=Fujimoto|first4=Tetsuho|last5=Jin|first5=Yu Fen|last6=Outani|first6=Hidetatsu|last7=Tamiya|first7=Hironari|last8=Naka|first8=Norifumi|last9=Araki|first9=Nobuhito|title=FDG-PET Evaluation of Chondromyxoid Fibroma of Left Ilium|journal=Clinical Nuclear Medicine|volume=34|issue=1|year=2009|pages=15–17|issn=0363-9762|doi=10.1097/RLU.0b013e31818f464b}}</ref> | On bone scans, the scintigraphic "doughnut sign" has been described in [[chondromyxoid fibroma]]. However, this is very nonspecific and can be seen in many other bone lesions.<ref name="HamadaTomita2009">{{cite journal|last1=Hamada|first1=Kenichiro|last2=Tomita|first2=Yasuhiko|last3=Konishi|first3=Eiichi|last4=Fujimoto|first4=Tetsuho|last5=Jin|first5=Yu Fen|last6=Outani|first6=Hidetatsu|last7=Tamiya|first7=Hironari|last8=Naka|first8=Norifumi|last9=Araki|first9=Nobuhito|title=FDG-PET Evaluation of Chondromyxoid Fibroma of Left Ilium|journal=Clinical Nuclear Medicine|volume=34|issue=1|year=2009|pages=15–17|issn=0363-9762|doi=10.1097/RLU.0b013e31818f464b}}</ref><ref name="MakisCiarallo2011">{{cite journal|last1=Makis|first1=William|last2=Ciarallo|first2=Anthony|last3=Lisbona|first3=Robert|title=Chondromyxoid fibroma of the rib mimics a chondrosarcoma on 18F-FDG PET/CT|journal=Acta Radiologica|volume=52|issue=5|year=2011|pages=554–556|issn=0284-1851|doi=10.1258/ar.2011.100526}}</ref><ref name="SubhawongWinn2017">{{cite journal|last1=Subhawong|first1=Ty K.|last2=Winn|first2=Aaron|last3=Shemesh|first3=Shai S.|last4=Pretell-Mazzini|first4=Juan|title=F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature|journal=Skeletal Radiology|volume=46|issue=9|year=2017|pages=1233–1239|issn=0364-2348|doi=10.1007/s00256-017-2685-7}}</ref> | ||
==References== | ==References== |
Revision as of 17:51, 13 June 2019
Fibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fibroma other imaging findings On the Web |
American Roentgen Ray Society Images of Fibroma other imaging findings |
Risk calculators and risk factors for Fibroma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Other imaging studies for ossifying fibroma include bone scan, which demonstrates mild hyperemia and moderate bone uptake during healing. However, in general they are negative.[1][1]
Other Imaging Findings
Bone Scan
Ossifying Fibroma
Appearance of ossifying fibroma depends on the phase of the lesion. In general they are negative; however, mild hyperaemia and moderate bone uptake are present during healing. If extensive uptake or hyperaemia are present, then an alternative diagnosis or superimposed fracture should be considered.[1]
Non ossifying fibroma
They are metabolically active on F18-FDG-PET images.That activity, probably is independent of lesion size, varies among patients and over time, as indicated by their F18-FDG uptake on PET. [2][3][4]
Chondromyxoid Fibroma
On bone scans, the scintigraphic "doughnut sign" has been described in chondromyxoid fibroma. However, this is very nonspecific and can be seen in many other bone lesions.[5][6][7]
References
- ↑ 1.0 1.1 1.2 Fibroma. Radiopedia(2015) http://radiopaedia.org/articles/chondromyxoid-fibroma Accessed on March 12, 2016
- ↑ Pagano M, Berta M, Postini AM, Bianchi M, Del Prever AB, Defilippi C, Ficola U, Cistaro A (2011). "Nonossifying fibroma: A possible pitfall in F18-FD-PET/CT imaging of Hodgkin's disease". Radiol Case Rep. 6 (2): 271. doi:10.2484/rcr.v6i2.271. PMC 4901151. PMID 27307893.
- ↑ Betsy M, Kupersmith LM, Springfield DS (2004). "Metaphyseal fibrous defects". J Am Acad Orthop Surg. 12 (2): 89–95. PMID 15089082.
- ↑ Goodin GS, Shulkin BL, Kaufman RA, McCarville MB (October 2006). "PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease". AJR Am J Roentgenol. 187 (4): 1124–8. doi:10.2214/AJR.06.0171. PMID 16985165.
- ↑ Hamada, Kenichiro; Tomita, Yasuhiko; Konishi, Eiichi; Fujimoto, Tetsuho; Jin, Yu Fen; Outani, Hidetatsu; Tamiya, Hironari; Naka, Norifumi; Araki, Nobuhito (2009). "FDG-PET Evaluation of Chondromyxoid Fibroma of Left Ilium". Clinical Nuclear Medicine. 34 (1): 15–17. doi:10.1097/RLU.0b013e31818f464b. ISSN 0363-9762.
- ↑ Makis, William; Ciarallo, Anthony; Lisbona, Robert (2011). "Chondromyxoid fibroma of the rib mimics a chondrosarcoma on 18F-FDG PET/CT". Acta Radiologica. 52 (5): 554–556. doi:10.1258/ar.2011.100526. ISSN 0284-1851.
- ↑ Subhawong, Ty K.; Winn, Aaron; Shemesh, Shai S.; Pretell-Mazzini, Juan (2017). "F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature". Skeletal Radiology. 46 (9): 1233–1239. doi:10.1007/s00256-017-2685-7. ISSN 0364-2348.